The re-emerging association between tuberculosis and diabetes: Lessons from past centuries.


Journal

Tuberculosis (Edinburgh, Scotland)
ISSN: 1873-281X
Titre abrégé: Tuberculosis (Edinb)
Pays: Scotland
ID NLM: 100971555

Informations de publication

Date de publication:
05 2019
Historique:
received: 02 11 2018
accepted: 02 11 2018
pubmed: 16 5 2019
medline: 30 1 2020
entrez: 16 5 2019
Statut: ppublish

Résumé

The association between tuberculosis (TB) and diabetes mellitus (DM) had a common place in the literature up to the first half of the 20th century, but virtually disappeared with the discovery of insulin to treat DM and antibiotics to cure TB. In the late 1990s the literature began to re-emerge with the worldwide increase in type 2 DM, particularly in TB-endemic countries. Today, type 2 DM is the most prevalent comorbidity among TB patients and the World Health Organization considers it a threat to TB control. We summarize the literature on TB and DM up to the 1960s. Then we evaluate unique aspects of this comorbidity in older times, such as the frequent diabetic comas that suggest challenges for proper DM management as insulin was being implemented, or the absence of antibiotics to cure TB. Despite the unique aspects of each study period, the literature across times is consistent in key aspects of the association. Namely, a higher TB prevalence among DM (versus non-DM patients), the importance of glucose control and chronic DM on TB susceptibility and the higher risk of death among patients with the co-morbidity. From the older literature, we can infer the likely contribution of type 1 DM to TB (in addition to type 2), regardless of their differing autoimmune or metabolic pathophysiology, respectively. Furthermore, in the older literature there was a notable reporting of DM development among TB patients, even though DM usually preceded TB. This observation deserves further epidemiological and basic studies to elucidate this intriguing aspect of the relationship between TB and DM.

Identifiants

pubmed: 31085129
pii: S1472-9792(19)30154-4
doi: 10.1016/j.tube.2019.04.015
pmc: PMC6626679
mid: NIHMS1528527
pii:
doi:

Types de publication

Historical Article Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S89-S97

Subventions

Organisme : NIA NIH HHS
ID : P01 AG051428
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116039
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Am J Epidemiol. 2008 Jun 15;167(12):1486-94
pubmed: 18400769
Chest. 2016 Jun;149(6):1501-8
pubmed: 26973015
Epidemiol Infect. 2007 Apr;135(3):483-91
pubmed: 16863600
Bull Indian Inst Hist Med Hyderabad. 1981;1-4:83-6
pubmed: 11616396
Sci Rep. 2017 May 17;7(1):1999
pubmed: 28515464
Am J Trop Med Hyg. 2008 Oct;79(4):541-4
pubmed: 18840741
Lancet Diabetes Endocrinol. 2018 May;6(5):361-369
pubmed: 29503172
J Prev Med Hyg. 2017 Mar;58(1):E9-E12
pubmed: 28515626
Acta Med Scand Suppl. 1958;335:1-48
pubmed: 13544883
BMC Med. 2011 Jul 01;9:81
pubmed: 21722362
Tuberculosis (Edinb). 2013 Dec;93 Suppl:S10-4
pubmed: 24388642
Am J Pathol. 2014 Apr;184(4):1104-1118
pubmed: 24492198
Tuberculosis (Edinb). 2018 Dec;113:10-18
pubmed: 30514492
Trans R Soc Trop Med Hyg. 2016 Mar;110(3):173-9
pubmed: 26884497
Chest. 2017 Jul;152(1):174-180
pubmed: 28434937
Diabetes Res Clin Pract. 2013 Oct;102(1):60-4
pubmed: 24035281
Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S2-8
pubmed: 21864746
Tuberculosis (Edinb). 2013 Mar;93(2):192-7
pubmed: 23131496
N Engl J Med. 2017 Apr 13;376(15):1419-1429
pubmed: 28402773
Clin Infect Dis. 2008 Sep 1;47(5):634-41
pubmed: 18652554
Int J Tuberc Lung Dis. 2009 Jul;13(7):868-74
pubmed: 19555537
J Infect Dis. 2016 Apr 1;213(7):1163-72
pubmed: 26609005
PLoS One. 2018 Mar 20;13(3):e0194127
pubmed: 29558518
PLoS One. 2017 Nov 21;12(11):e0187967
pubmed: 29161276
PLoS One. 2013 Nov 13;8(11):e78924
pubmed: 24236069
Clin Infect Dis. 2017 Jan 15;64(2):111-115
pubmed: 28052967
Respir Med. 2006 Nov;100(11):1862-70
pubmed: 16949809
Nature. 2001 Dec 13;414(6865):813-20
pubmed: 11742414
J Infect Dis. 2016 Dec 1;214(11):1629-1637
pubmed: 27630197
Eur J Immunol. 2014 Mar;44(3):617-26
pubmed: 24448841
Bull Indian Inst Hist Med Hyderabad. 1999 Jan;29(1):83-7
pubmed: 12585294
Lancet Diabetes Endocrinol. 2014 Dec;2(12):932
pubmed: 25433427
Clin Chem. 2002 Dec;48(12):2270-88
pubmed: 12446492
Am Rev Tuberc. 1952 Jan;65(1:2):1-50
pubmed: 14885713
Clin Infect Dis. 2012 Mar;54(6):818-25
pubmed: 22238171
J Immunol. 2010 Jun 1;184(11):6275-82
pubmed: 20421645
Clin Infect Dis. 2010 May 15;50 Suppl 3:S201-7
pubmed: 20397949
Bull World Health Organ. 2011 May 1;89(5):352-9
pubmed: 21556303
Trop Med Int Health. 2010 Jun;15(6):659-63
pubmed: 20406430
Diabetes Care. 2014 Jan;37 Suppl 1:S14-80
pubmed: 24357209
J Antibiot (Tokyo). 2014 Sep;67(9):661-5
pubmed: 25095803
PLoS Pathog. 2016 Oct 26;12(10):e1005972
pubmed: 27783671
Chest. 2017 Jul;152(1):165-173
pubmed: 28434936
Clin Exp Optom. 1999 Mar-Jun;82(2-3):102-106
pubmed: 12482299
Lancet Diabetes Endocrinol. 2015 Aug;3(8):624-37
pubmed: 26109024

Auteurs

Jose Cadena (J)

University of Texas Health, San Antonio, TX 78229, USA; South Texas Veterans Health Care System, San Antonio TX 78229, USA. Electronic address: cadenazuluag@uthscsa.edu.

Selvalakshmi Rathinavelu (S)

University of Texas Health Houston, School of Public Health, Brownsville Campus, Brownsville, TX 78520, USA. Electronic address: dr.selvalakshmi@gmail.com.

Juan C Lopez-Alvarenga (JC)

University of Texas Rio Grande Valley, South Texas Diabetes and Obesity Institute, School of Medicine, Edinburg, TX 78541, USA.

Blanca I Restrepo (BI)

University of Texas Health Houston, School of Public Health, Brownsville Campus, Brownsville, TX 78520, USA; University of Texas Rio Grande Valley, South Texas Diabetes and Obesity Institute, School of Medicine, Edinburg, TX 78541, USA. Electronic address: blanca.i.restrepo@uth.tmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH